Office Hours for Prospective Applicants
Our program is hosting virtual “office hours,” during which one of our co-directors will be present. These are a chance for prospective applicants to ask questions about the program, and learn about it more directly. The following time slots are available (all times listed in Pacific Time):
- Tuesday, Oct 31, 10 – 11am (completed)
- Wednesday, Nov 15, 1 – 2pm (completed)
- Thursday, Dec 21, 2 – 3pm (completed)
- Wednesday, Jan 3, 9:30 – 10:30am
If you would like to join one of these sessions, please send an email with your name and preferred session to firstname.lastname@example.org. You will then be send a calendar invitation with the Zoom details.
Beginning in September 2023, we have expanded the UBC MSc in Genetic Counselling Program to offer 8 seats (previously 6) for incoming classes. Two of these seats spend the first term of their second year training in Victoria, BC. The Victoria seats will be offered as a specific track within the NMS Match service, and only applicants who select this track option will match to it.
CAGC Meet a GC Program
As of October 2022, the Canadian Association of Genetic Counsellors (CAGC) is offering prospective students a chance to connect with current genetic counsellors. For more details, please visit the CAGC website: https://www.cagc-accg.ca/?page=372.
Exposure to the profession of genetic counselling
We recognize that opportunities to gain exposure to the field can be challenging. We encourage applicants to find alternate ways of gaining insight into the field. This can include informational interviews with genetic counsellors across different practice areas, reading the Journal of Genetic Counselling to understand the issues and the research that are active in the field, and online sources such as NSGC, CAGC, and Master Genetic Counselor videos available through NSGC.
Neurodegenerative Disease Interview Series: Emily Dwosh
As part of the UBC Synapse Neurodegenerative Disease Interview Series, alumna Emily Dwosh discussed genetic counselling in the context of Alzheimer disease and other disorders. Watch the interview here.